From Name

From Email

To Name

To Email

Message

High-dose chemo most benefits patients with high-risk breast cancer

from AJMC

High-dose chemo most benefits patients with high-risk breast cancer AJMC A 20-year follow-up comprising a secondary analysis to an original study shows that high-dose chemotherapy plus hematopoietic stem cell transplant benefit patients with high-risk stage III disease with 10 or more axillary lymph nodes involved. READ MORE

more